Antibody Discovery Market Expected to Grow at a CAGR 8.9% from 2023 to 2031 | InsightAce Analytic
Companies covered in this report are Danaher Corporation, Evotec, Biocytogen, Genscript Technology Corporation, Eurofins Scientific, Creative Biolabs, Charles River Laboratories, Sartorius AG, Twist Bioscience, and Fairjourney Biologics S.A.
Jersey City, NJ, Dec. 19, 2023 (GLOBE NEWSWIRE) — InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Antibody discovery Market Size, Share & Trends Analysis Report By Methods (Phage Display, Hybridoma, and Others), By Antibody Type (Humanized Antibody, Human Antibody, Chimeric Antibody, and Murine Antibody), By End User (Pharmaceutical and Biotechnology Industry, Research Laboratory, and Academic Laboratory), Region, Market Outlook And Industry Analysis 2031”
The global antibody discovery market is estimated to reach over USD 14.5 billion by 2031, exhibiting a CAGR of 8.9% during the forecast period.
Antibody discovery refers to the process of seeking out new antibodies. The strategy’s end goal is to identify diagnostic or therapeutic antibodies with target-binding and detection capabilities. Hybridoma technologies and phage displays are commonly used in antibody production. Essential for developing novel therapeutics such as vaccines, diagnostic tools, and drugs, this technology allows researchers to construct antibodies that can recognize and target specific antigens. As the prevalence of chronic diseases such as cancer, diabetes, cardiovascular disease, and autoimmune disorders continues to rise alarmingly, the antibody discovery sector is seeing unprecedented growth. As the prevalence of long-term health problems rises, so does the desire for effective therapies, driving up the price of antibody discovery services.
The antibody discovery sector is also anticipated to benefit from the growing consumer consciousness of the importance of individualized treatment. By analyzing past biological data through genetic and biomarker testing, the purpose of personalized medicine is to customize medical therapy. Personalized medicine relies on the development of disease-specific antibodies. However, the research and identification of antibodies can be a laborious and costly procedure. The hefty price tags attached to research, preclinical and clinical trials, and manufacturing hinder access to antibody therapeutics.
Free PDF Report Brochure @ https://www.insightaceanalytic.com/request-sample/2287
- In October 2023, Evotec S.E. announced that the innovative insomnia therapy EVT201, which is also known as Dimdazenil in China, has been authorized by the “NMPA” in China, the country’s official medical product regulator and that Zhejiang Jingxin Pharmaceutical Co. Ltd (“Jingxin”) is the company responsible for this approval.
- In September 2023, Biocytogen Pharmaceuticals is pleased to announce that the U.S. Patent and Trademark Office has granted a patent to its proprietary platform for therapeutic antibody development, the RenMabTM mice. The patent with the number US-11730151-B2 protects the central technology of these mice.
List of Prominent Players in the Antibody discovery market:
- Danaher Corporation
- Genscript Technology Corporation
- Eurofins Scientific
- Creative Biolabs
- Charles River Laboratories
- Sartorius AG
- Twist Bioscience
- Fairjourney Biologics S.A.
The growing demand for the antibody discovery market is fueled by the growing number of infectious disorders and the availability of therapeutic antibodies, which is a major factor propelling the market. Improvements in recombinant antibody production, antibody engineering and design, and targeted medicines have resulted from the rise of personalized medicine. The antibody discovery market is growing due to the increasing number of collaborations between pharmaceutical corporations, biotechnology firms, and academic research institutes. These collaborations frequently entail antibody sequencing services, immune repertoire analysis, and single-cell sequencing for antibody identification.
The prime challenge is strict regulations, a shortage of competent individuals and a lack of norms and protocol because of lockdowns and isolation in emerging countries, which is predicted to slow the growth of the Antibody discovery market. The business is anticipated to be limited by the high costs associated with antibody discovery, hindering broad implementation. This factor will hinder the market’s expansion during the predicted period. The challenge in developing long-term effective treatments for antibody discovery cancers is exacerbated by this resistance phenomenon, which forces researchers to seek new ways to avoid and overcome these adaptive mechanisms. In addition, the COVID-19 pandemic has significantly impacted antibody research and development. The search for effective and selective antibodies has progressed considerably because of new strategies, better technology, and increased funding for research. Also, the global market for antibody discovery stands to benefit from the COVID-19 pandemic.
The North American antibody discovery market is anticipated to register a significant market share in terms of revenue. It is projected to grow at a high CAGR shortly due to more investment in research and development and an increase in cancer cases associated with antibody discovery. Besides, Europe had a substantial market share due to technological advancements and affluence. The demand for targeted treatments in oncology, improvements in healthcare infrastructure, the frequency of antibody discovery in different cancer types, and the pace of drug discovery and development are all potential drivers of market expansion in this field.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2287
Segmentation of Antibody Discovery Market-
- Phage Display
By Antibody Type-
- Humanized Antibody
- Human Antibody
- Chimeric Antibody
- Murine Antibody
By End User-
- Pharmaceutical and Biotechnology Industry
- Research Laboratory
- Academic Laboratory
- The US
- The UK
- Rest of Europe
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Read Report Snapshot: https://www.insightaceanalytic.com/report/antibody-discovery-market/2287
InsighAce Analytic is a specializing in market research and consulting services that helps in building business strategies. Our mission is to provide high quality insights with using data analytics techniques and visualization tools that drives the disruption and innovation in market research industry. Our expertise is in providing syndicated and custom market intelligence reports with in-depth analysis and key market insights in a timely and cost-effective manner.
Subscribe Our Exclusive Newsletters @ https://www.linkedin.com/newsletters/latest-market-research-reports-6929319878155739136/
CONTACT: Contact Us: InsightAce Analytic Pvt. Ltd. Tel.: +1 551 226 6109 Email: [email protected] Site Visit: https://www.insightaceanalytic.com
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.